This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Starton Therapeutics, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Yuliya C Levintova: Innovator in Immunomodulatory Treatments
Introduction
Yuliya C Levintova is a prominent inventor based in Brooklyn, NY (US). She has made significant contributions to the field of immunomodulatory treatments, holding 2 patents that focus on innovative methods for administering vital medications.
Latest Patents
Her latest patents include the "Continuous delivery of lenalidomide and other immunomodulatory agents." This patent provides systems and methods for continuously administering a formulation comprising an immunomodulatory imide compound to a subject in need of treatment. The methods are particularly aimed at treating conditions such as multiple myeloma, transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes, mantle cell lymphoma, hematologic cancers, or solid tumor cancers.
Career Highlights
Yuliya is currently associated with Starton Therapeutics, Inc., where she continues to advance her research and development efforts in the field of immunotherapy. Her work is crucial in improving treatment options for patients suffering from various types of cancers.
Collaborations
Yuliya collaborates with notable professionals in her field, including Marina Borovinskaya and Fotios M Plakogiannis. These collaborations enhance her research and contribute to the innovative solutions being developed at Starton Therapeutics.
Conclusion
Yuliya C Levintova is a dedicated inventor whose work in immunomodulatory treatments is paving the way for new therapeutic options. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile